Idiopathic Parkinson's disease patients at the urologic clinic

Ragab, Maged; Mohammed, Ehab S.

doi:10.1002/nau.20983

Cited by 47 publications

(39 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…1,4,6 The current management involves not only palliation of neurological and motor deterioration, but also improvement of NDO symptoms significantly affecting the QoL of patients. 6 Different managements, including the use of pharmacotherapy and surgery have been proposed, but they usually do not restore functional synergy.…”

Section: 5 Lutsmentioning

confidence: 99%

See 1 more Smart Citation

The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease

Kabay

Çetiner

et al. 2016

Urology

View full text Add to dashboard Cite

Section: 5 Lutsmentioning

confidence: 99%

“…LUTS in PD have not been shown as a significant threatening cause of upper urinary tract involment because of patients with PD suffers from NDO bladder without detrusor sphincter dysynergia (DSD). 4…”

Section: Introductionmentioning

confidence: 99%

The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease

Kabay

Çetiner

et al. 2016

Urology

View full text Add to dashboard Cite

“…Reduction in nigrostriatal dopamine (specifically, diminished or absent D1 receptor stimulation) leads to partial or total disconnection of the micturition reflex from voluntary control and, in turn, uninhibited bladder contractions in the presence of negligible volumes of urine (Blackett et al, 2009;Gray, Stern, & MaloneLee, 1995;Katz & Greenstein, 1989;Ransmayr et al, 2008;Singer, 2005;Singer, Weiner, & Sanchez-Ramos, 1992;Siroky, 2003). This is generally referred to as detrusor hyperreflexia or detrusor overactivity (DH/DO), the most common urodynamic pattern in patients with PD (Chancellor & Blaivas, 1991;Katz & Greenstein, 1989;Fitzmaurice et al, 1985;Ragab & Mohammed, 2011;Siroky, 2003). Symptoms reported by patients with PD and DH/DO include urinary urgency and frequency, nocturia, and urge UI (Araki & Kuno, 2000;Blackett et al, 2009;Ragab & Mohammed, 2011;Ransmayr et al, 2008;Sakakibara et al, 2001a;Stacy, 1999).…”

Section: Background/literature Reviewmentioning

confidence: 99%

“…This is generally referred to as detrusor hyperreflexia or detrusor overactivity (DH/DO), the most common urodynamic pattern in patients with PD (Chancellor & Blaivas, 1991;Katz & Greenstein, 1989;Fitzmaurice et al, 1985;Ragab & Mohammed, 2011;Siroky, 2003). Symptoms reported by patients with PD and DH/DO include urinary urgency and frequency, nocturia, and urge UI (Araki & Kuno, 2000;Blackett et al, 2009;Ragab & Mohammed, 2011;Ransmayr et al, 2008;Sakakibara et al, 2001a;Stacy, 1999).…”

Section: Background/literature Reviewmentioning

confidence: 99%

Lower Urinary Tract Symptoms in Men With Parkinson Disease

Robinson¹,

Bradway²,

Bunting-Perry³

et al. 2013

Journal of Neuroscience Nursing

View full text Add to dashboard Cite

Assessment for LUTS should be a component of every evaluation of a patient with PD. Our findings offer a preliminary profile of the male PD patient with LUTS, which is an important step toward effective screening, detection, and access to care and treatment. Next steps in research include further work to identify predictors of LUTS in both male and female PD populations, explore patient perspectives, begin trials of interventions for LUTS in the PD population, and analyze the economic impact.

show abstract

“…The irritative urinary symptoms manifested urodynamically as neurogenic detrusor overactivity are more common in IPD patients than obstructive symptoms. 46 One study investigated the LUTS and urodynamic and cystometric findings in PD, dementia with Lewy bodies, and Alzheimer's disease (AD). Urgency and urge incontinence are more prevalent in dementia with Lewy bodies than in PD and AD, whereas mean voided volume, free flow, cystometric bladder capacity, and detrusor pressure were similar in the groups; DO in 92% of the patients with dementia with Lewy bodies, 46% of the patients with PD, and 40% of the patients with AD.…”

Section: Oab Questionnairesmentioning

confidence: 99%

Clinical guidelines for male lower urinary tract symptoms associated with non-neurogenic overactive bladder

2015

View full text Add to dashboard Cite

Keywords: benign prostatic hyperplasia guideline lower urinary tract symptoms overactive bladder a b s t r a c tThe purpose of this guideline is to direct urologists and patients regarding how to identify overactive bladder (OAB) in male patients with lower urinary tract symptoms (LUTS) and to make an accurate diagnosis and establish treatment goals to improve the patients' quality of life (QoL). LUTS are commonly divided into storage, voiding, and postmicturition symptoms, and are highly prevalent in elderly men. LUTS can result from a complex interplay of pathophysiologic features that can include bladder dysfunction and bladder outlet dysfunction such as benign prostatic obstruction (BPO) or poor relaxation of the urethral sphincter. Diagnosis of OAB in male LUTS leads to accurate diagnosis of pure OAB and bladder outlet-related OAB, and appropriate treatment in men with residual storage symptoms after treatment for LUTS. PurposeThe purpose of this guideline is to direct urologists and patients regarding how to identify overactive bladder (OAB) from male patients with lower urinary tract symptoms (LUTS) and to make an accurate diagnosis and establish treatment goals to improve patients' quality of life (QoL). Male LUTS and OAB e background2.1. LUTS are highly prevalent among older men and have a negative impact on health-related QoL (HRQoL). (LE 1a, Grade A) OAB is associated with medical diseases such as diabetes and congestive heart failure. (LE 2b, Grade B) OAB and urinary incontinence symptom severity progress dynamically and are also sustained over time. (LE 2a, Grade B) OAB is a clinical diagnosis defined by the International Continence Society as the presence of "urinary urgency, usually accompanied by frequency and nocturia, with or without urgency urinary incontinence, in the absence of a urinary tract infection or other obvious pathology". 1 OAB symptoms can be bothersome and can negatively affect HRQoL, increase anxiety and depression, and increase health care usage. The strongest predictor of OAB-associated bother was urinary urgency. 2 OAB also adversely affects sexuality in both men and women. 3 OAB is common in older adults and is associated with substantial impairment in mental health and HRQoL, but rates of treatment seeking behavior are low. 4 Urgency is the core symptom for the presence of OAB. It has been estimated that 10e16% of the population in the world has the OAB condition. 5 However, although an urgency severity scale has been suggested, the grade of urgency is reported subjectively by the patients; therefore, there could be a wide variation among different grades of the reported urgency severity. 6 The incidence of LUTS, including OAB in men, increases with age. Frequent comorbidity with potential prostatic disease adds complexity to the management of male LUTS. 7 In addition, patients with congestive heart failure had more storage urinary symptoms suggestive of OAB than did the age-matched controls. 8 Patients with type 2 diabetes mellitus present more OAB symptoms such as urgen...

show abstract

Idiopathic Parkinson's disease patients at the urologic clinic

Cited by 47 publications

References 33 publications

The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease

The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease

Lower Urinary Tract Symptoms in Men With Parkinson Disease

Clinical guidelines for male lower urinary tract symptoms associated with non-neurogenic overactive bladder

Contact Info

Product

Resources

About